A citation-based method for searching scientific literature

C Frank Bennett. Annu Rev Med 2019
Times Cited: 204







List of co-cited articles
858 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


RNA-Targeted Therapeutics.
Stanley T Crooke, Joseph L Witztum, C Frank Bennett, Brenda F Baker. Cell Metab 2018
361
19

Advances in oligonucleotide drug delivery.
Thomas C Roberts, Robert Langer, Matthew J A Wood. Nat Rev Drug Discov 2020
499
19

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.
David Adams, Alejandra Gonzalez-Duarte, William D O'Riordan, Chih-Chao Yang, Mitsuharu Ueda, Arnt V Kristen, Ivailo Tournev, Hartmut H Schmidt, Teresa Coelho, John L Berk,[...]. N Engl J Med 2018
14

Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides.
Richard S Geary, Daniel Norris, Rosie Yu, C Frank Bennett. Adv Drug Deliv Rev 2015
454
13

The chemical evolution of oligonucleotide therapies of clinical utility.
Anastasia Khvorova, Jonathan K Watts. Nat Biotechnol 2017
506
12

Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice.
Thazha P Prakash, Mark J Graham, Jinghua Yu, Rick Carty, Audrey Low, Alfred Chappell, Karsten Schmidt, Chenguang Zhao, Mariam Aghajan, Heather F Murray,[...]. Nucleic Acids Res 2014
322
11


Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.
A Fire, S Xu, M K Montgomery, S A Kostas, S E Driver, C C Mello. Nature 1998
11

The current state and future directions of RNAi-based therapeutics.
Ryan L Setten, John J Rossi, Si-Ping Han. Nat Rev Drug Discov 2019
520
11

GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.
Aaron D Springer, Steven F Dowdy. Nucleic Acid Ther 2018
219
11

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.
Merrill D Benson, Márcia Waddington-Cruz, John L Berk, Michael Polydefkis, Peter J Dyck, Annabel K Wang, Violaine Planté-Bordeneuve, Fabio A Barroso, Giampaolo Merlini, Laura Obici,[...]. N Engl J Med 2018
649
10

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy.
Eugenio Mercuri, Basil T Darras, Claudia A Chiriboga, John W Day, Craig Campbell, Anne M Connolly, Susan T Iannaccone, Janbernd Kirschner, Nancy L Kuntz, Kayoko Saito,[...]. N Engl J Med 2018
656
10

Cellular uptake and trafficking of antisense oligonucleotides.
Stanley T Crooke, Shiyu Wang, Timothy A Vickers, Wen Shen, Xue-Hai Liang. Nat Biotechnol 2017
282
10

Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study.
Richard S Finkel, Claudia A Chiriboga, Jiri Vajsar, John W Day, Jacqueline Montes, Darryl C De Vivo, Mason Yamashita, Frank Rigo, Gene Hung, Eugene Schneider,[...]. Lancet 2016
567
10

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.
S M Elbashir, J Harborth, W Lendeckel, A Yalcin, K Weber, T Tuschl. Nature 2001
10

Givosiran: First Approval.
Lesley J Scott. Drugs 2020
148
9

Pharmacology of Antisense Drugs.
C Frank Bennett, Brenda F Baker, Nguyen Pham, Eric Swayze, Richard S Geary. Annu Rev Pharmacol Toxicol 2017
227
9

Antisense oligonucleotides targeting translation inhibitory elements in 5' UTRs can selectively increase protein levels.
Xue-Hai Liang, Hong Sun, Wen Shen, Shiyu Wang, Joyee Yao, Michael T Migawa, Huynh-Hoa Bui, Sagar S Damle, Stan Riney, Mark J Graham,[...]. Nucleic Acids Res 2017
48
18

Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing.
Jayaprakash K Nair, Jennifer L S Willoughby, Amy Chan, Klaus Charisse, Md Rowshon Alam, Qianfan Wang, Menno Hoekstra, Pachamuthu Kandasamy, Alexander V Kel'in, Stuart Milstein,[...]. J Am Chem Soc 2014
560
8

The delivery of therapeutic oligonucleotides.
Rudolph L Juliano. Nucleic Acids Res 2016
474
8

Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading frames.
Xue-Hai Liang, Wen Shen, Hong Sun, Michael T Migawa, Timothy A Vickers, Stanley T Crooke. Nat Biotechnol 2016
86
9

STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial.
Matthew J Reilley, Patricia McCoon, Carl Cook, Paul Lyne, Razelle Kurzrock, Youngsoo Kim, Richard Woessner, Anas Younes, John Nemunaitis, Nathan Fowler,[...]. J Immunother Cancer 2018
122
8

Safety of antisense oligonucleotide and siRNA-based therapeutics.
Xuan Chi, Philip Gatti, Thomas Papoian. Drug Discov Today 2017
134
8

Antisense technology: an overview and prospectus.
Stanley T Crooke, Brenda F Baker, Rosanne M Crooke, Xue-Hai Liang. Nat Rev Drug Discov 2021
113
8

The Medicinal Chemistry of Therapeutic Oligonucleotides.
W Brad Wan, Punit P Seth. J Med Chem 2016
165
7

Phosphorothioate modified oligonucleotide-protein interactions.
Stanley T Crooke, Timothy A Vickers, Xue-Hai Liang. Nucleic Acids Res 2020
80
8

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study.
Timothy M Miller, Alan Pestronk, William David, Jeffrey Rothstein, Ericka Simpson, Stanley H Appel, Patricia L Andres, Katy Mahoney, Peggy Allred, Katie Alexander,[...]. Lancet Neurol 2013
419
7

Targeting Huntingtin Expression in Patients with Huntington's Disease.
Sarah J Tabrizi, Blair R Leavitt, G Bernhard Landwehrmeyer, Edward J Wild, Carsten Saft, Roger A Barker, Nick F Blair, David Craufurd, Josef Priller, Hugh Rickards,[...]. N Engl J Med 2019
328
7

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy.
Richard S Finkel, Eugenio Mercuri, Basil T Darras, Anne M Connolly, Nancy L Kuntz, Janbernd Kirschner, Claudia A Chiriboga, Kayoko Saito, Laurent Servais, Eduardo Tizzano,[...]. N Engl J Med 2017
978
7

The powerful world of antisense oligonucleotides: From bench to bedside.
Anaïs M Quemener, Laura Bachelot, Anne Forestier, Emmanuelle Donnou-Fournet, David Gilot, Marie-Dominique Galibert. Wiley Interdiscip Rev RNA 2020
79
8

The current landscape of nucleic acid therapeutics.
Jayesh A Kulkarni, Dominik Witzigmann, Sarah B Thomson, Sam Chen, Blair R Leavitt, Pieter R Cullis, Roy van der Meel. Nat Nanotechnol 2021
154
7

Therapeutic siRNA: state of the art.
Bo Hu, Liping Zhong, Yuhua Weng, Ling Peng, Yuanyu Huang, Yongxiang Zhao, Xing-Jie Liang. Signal Transduct Target Ther 2020
268
7

Therapeutic Oligonucleotides: State of the Art.
C I Edvard Smith, Rula Zain. Annu Rev Pharmacol Toxicol 2019
138
6



Single-stranded siRNAs activate RNAi in animals.
Walt F Lima, Thazha P Prakash, Heather M Murray, Garth A Kinberger, Wenyu Li, Alfred E Chappell, Cheryl S Li, Susan F Murray, Hans Gaus, Punit P Seth,[...]. Cell 2012
175
6

Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index.
Wen Shen, Cheryl L De Hoyos, Michael T Migawa, Timothy A Vickers, Hong Sun, Audrey Low, Thomas A Bell, Meghdad Rahdar, Swagatam Mukhopadhyay, Christopher E Hart,[...]. Nat Biotechnol 2019
121
6

AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer.
David Hong, Razelle Kurzrock, Youngsoo Kim, Richard Woessner, Anas Younes, John Nemunaitis, Nathan Fowler, Tianyuan Zhou, Joanna Schmidt, Minji Jo,[...]. Sci Transl Med 2015
262
6

Integrated Assessment of the Clinical Performance of GalNAc3-Conjugated 2'-O-Methoxyethyl Chimeric Antisense Oligonucleotides: I. Human Volunteer Experience.
Stanley T Crooke, Brenda F Baker, Shuting Xia, Rosie Z Yu, Nicholas J Viney, Yanfeng Wang, Sotirios Tsimikas, Richard S Geary. Nucleic Acid Ther 2019
57
10

Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
Sotirios Tsimikas, Ewa Karwatowska-Prokopczuk, Ioanna Gouni-Berthold, Jean-Claude Tardif, Seth J Baum, Elizabeth Steinhagen-Thiessen, Michael D Shapiro, Erik S Stroes, Patrick M Moriarty, Børge G Nordestgaard,[...]. N Engl J Med 2020
320
6

N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels.
Veronica J Alexander, Shuting Xia, Eunju Hurh, Steven G Hughes, Louis O'Dea, Richard S Geary, Joseph L Witztum, Sotirios Tsimikas. Eur Heart J 2019
109
6

Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy.
Diane E Frank, Frederick J Schnell, Cody Akana, Saleh H El-Husayni, Cody A Desjardins, Jennifer Morgan, Jay S Charleston, Valentina Sardone, Joana Domingos, George Dickson,[...]. Neurology 2020
124
6

Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.
Joseph L Witztum, Daniel Gaudet, Steven D Freedman, Veronica J Alexander, Andres Digenio, Karren R Williams, Qingqing Yang, Steven G Hughes, Richard S Geary, Marcello Arca,[...]. N Engl J Med 2019
211
6

Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides.
Mark J Graham, Richard G Lee, Teresa A Brandt, Li-Jung Tai, Wuxia Fu, Raechel Peralta, Rosie Yu, Eunju Hurh, Erika Paz, Bradley W McEvoy,[...]. N Engl J Med 2017
362
6

Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Timothy Miller, Merit Cudkowicz, Pamela J Shaw, Peter M Andersen, Nazem Atassi, Robert C Bucelli, Angela Genge, Jonathan Glass, Shafeeq Ladha, Albert L Ludolph,[...]. N Engl J Med 2020
191
6


Patisiran: First Global Approval.
Sheridan M Hoy. Drugs 2018
238
6


Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides.
Elizabeth J Ackermann, Shuling Guo, Merrill D Benson, Sheri Booten, Sue Freier, Steven G Hughes, Tae-Won Kim, T Jesse Kwoh, John Matson, Dan Norris,[...]. Amyloid 2016
86
5

Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates.
Donald J Foster, Christopher R Brown, Sarfraz Shaikh, Casey Trapp, Mark K Schlegel, Kun Qian, Alfica Sehgal, Kallanthottathil G Rajeev, Vasant Jadhav, Muthiah Manoharan,[...]. Mol Ther 2018
124
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.